CEKRX
Price
$20.29
Change
+$0.60 (+3.05%)
Updated
Jul 31 closing price
Net Assets
790.55M
RNWEX
Price
$105.35
Change
+$2.04 (+1.97%)
Updated
Jul 31 closing price
Net Assets
90.71B
Interact to see
Advertisement

CEKRX vs RNWEX

CEKRX vs RNWEX Comparison Chart in %
View a ticker or compare two or three
VS
CEKRX vs. RNWEX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEKRX is a Hold and RNWEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 90.7B vs. CEKRX (791M). RNWEX pays higher dividends than CEKRX: RNWEX (0.99) vs CEKRX (0.34). CEKRX was incepted earlier than RNWEX: CEKRX (14 years) vs RNWEX (24 years). CEKRX (1.24) is less costly to investors than RNWEX (0.92). CEKRX is a more actively managed with annual turnover of: 56.00 vs. RNWEX (46.00). CEKRX has a lower initial minimum investment than RNWEX: CEKRX (0) vs RNWEX (250). CEKRX annual gain was more profitable for investors over the last year : 34.50 vs. RNWEX (21.57). RNWEX return over 5 years is better than : 17.03 vs. CEKRX (10.60).
CEKRXRNWEXCEKRX / RNWEX
Total Expense Ratio1.040.92113%
Annual Report Gross Expense Ratio1.240.92135%
Fund Existence14 years24 years-
Gain YTD22.22913.843161%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets791M90.7B1%
Annual Yield % from dividends0.340.9935%
Returns for 1 year34.5021.57160%
Returns for 3 years62.3343.61143%
Returns for 5 years10.6017.0362%
Returns for 10 years111.79107.28104%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAUX14.480.13
+0.91%
Nationwide GQG US Quality Eq A
VWNDX24.560.09
+0.37%
Vanguard Windsor Investor Shares
WDIIX17.060.01
+0.06%
Wilmington Enhanced Div Inc Strat I
PJSQX27.68-0.03
-0.11%
PGIM Jennison Small Company R6
MCRFX15.21-0.13
-0.85%
BlackRock Mid-Cap Value Investor C